{
  "id": 11435493,
  "title": "Autonomix receives Canadian patent for nerve therapy technology",
  "url": "https://urgent.news/2026/10/02/autonomix-receives-canadian-patent-for-nerve-therapy-technology",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-02T12:12:31.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/autonomix-receives-canadian-patent-for-nerve-therapy-technology-93CH-4929685"
  },
  "original_language": "en",
  "account": null,
  "summary": "Autonomix Medical Inc. has been granted a Canadian patent for its catheter-based transvascular intervention technology, covering systems, methods, and devices for monitoring and treatment of tissues within and/or through a lumen wall. The patent, No. 3,183,802, protects catheter-based tools designed to deploy probes through a lumen wall to access and treat nerves located outside the vessel. The technology incorporates multi-site electrophysiological sensing capabilities, real-time feedback for adjusting stimulation or therapeutic energy delivery, and closed-loop control mechanisms. With 112 issued or pending patent applications worldwide, Autonomix Medical strengthens its intellectual property portfolio, which includes patents in the United States and Europe.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}